Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

Similar articles for PubMed (Select 20130384)

1.

Linear IgA disease: successful application of immunoadsorption and review of the literature.

Kasperkiewicz M, Meier M, Zillikens D, Schmidt E.

Dermatology. 2010;220(3):259-63. doi: 10.1159/000279318. Epub 2010 Feb 3. Review.

PMID:
20130384
2.

Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180.

Kromminga A, Scheckenbach C, Georgi M, Hagel C, Arndt R, Christophers E, Bröcker EB, Zillikens D.

J Autoimmun. 2000 Nov;15(3):293-300.

PMID:
11040070
3.

Linear IgA disease: successful treatment with erythromycin.

Cooper SM, Powell J, Wojnarowska F.

Clin Exp Dermatol. 2002 Nov;27(8):677-9.

PMID:
12472545
4.
5.

Linear IgA bullous dermatosis. Characterization of a subset of patients with concurrent IgA and IgG anti-basement membrane autoantibodies.

Chan LS, Traczyk T, Taylor TB, Eramo LR, Woodley DT, Zone JJ.

Arch Dermatol. 1995 Dec;131(12):1432-7.

PMID:
7492134
6.

Autoantibodies in a subgroup of patients with linear IgA disease react with the NC16A domain of BP1801.

Zillikens D, Herzele K, Georgi M, Schmidt E, Chimanovitch I, Schumann H, Mascaro JM Jr, Diaz LA, Bruckner-Tuderman L, Bröcker EB, Giudice GJ.

J Invest Dermatol. 1999 Dec;113(6):947-53.

9.

Sensorineural hearing loss in linear IgA disease.

Hari CK, Hanif J, Frosh A.

Int J Clin Pract. 2001 Oct;55(8):571-2.

PMID:
11695083
10.

Successful adjuvant treatment of severe bullous pemphigoid by tryptophan immunoadsorption.

Herrero-González JE, Sitaru C, Klinker E, Bröcker EB, Zillikens D.

Clin Exp Dermatol. 2005 Sep;30(5):519-22.

PMID:
16045683
11.

Linear IgA dermatosis in an immunosuppressed patient after allogenic bone marrow transplantation.

Schultewolter T, Goos M, Dissemond J.

J Eur Acad Dermatol Venereol. 2004 Nov;18(6):721-5.

PMID:
15482308
12.

Linear IgA dermatosis with IgA and IgG autoantibodies to the 180 kDa bullous pemphigoid antigen (BP180): evidence for a distinct subtype.

Metz BJ, Ruggeri SY, Hsu S, Reed JA, Ghohestani AS, Uitto J, Ghohestani RF.

Int J Dermatol. 2004 Jun;43(6):443-6.

PMID:
15186228
13.

A child with antibodies targeting both linear IgA bullous dermatosis and bullous pemphigoid antigens.

Darling TN, Cardenas AA, Beard JS, Sau P, Yee CL, Zone JJ, Yancey KB.

Arch Dermatol. 1995 Dec;131(12):1438-42.

PMID:
7492135
14.

Linear IgA disease and pregnancy.

Collier PM, Kelly SE, Wojnarowska F.

J Am Acad Dermatol. 1994 Mar;30(3):407-11.

PMID:
8113452
15.

Autoimmune subepidermal blistering diseases in Uganda: correlation of autoantibody class with age of patients.

Mulyowa GK, Jaeger G, Kabakyenga J, Bröcker EB, Zillikens D, Schmidt E.

Int J Dermatol. 2006 Sep;45(9):1047-52.

PMID:
16961507
16.

Juvenile blistering diseases: the problems of diagnosis and treatment.

Piamphongsant T, Sirimachan S, Himmunknan P.

Asian Pac J Allergy Immunol. 1986 Dec;4(2):133-7.

PMID:
3541947
17.

Dermal-binding linear IgA disease: an uncommon subset of a rare immunobullous disease.

Lally A, Chamberlain A, Allen J, Dean D, Wojnarowska F.

Clin Exp Dermatol. 2007 Sep;32(5):493-8. Epub 2007 Apr 24.

PMID:
17459072
18.

IgA pemphigus: the first two Scandinavian cases.

Gniadecki R, Bygum A, Clemmensen O, Svejgaard E, Ullman S.

Acta Derm Venereol. 2002;82(6):441-5.

PMID:
12575851
19.

Association between the subepidermal autoimmune blistering diseases linear IgA disease and the pemphigoid group and inflammatory bowel disease: two case reports and literature review.

Shipman AR, Reddy H, Wojnarowska F.

Clin Exp Dermatol. 2012 Jul;37(5):461-8. doi: 10.1111/j.1365-2230.2012.04383.x. Review.

PMID:
22712854
20.

IgA-mediated epidermolysis bullosa acquisita: two cases and review of the literature.

Vodegel RM, de Jong MC, Pas HH, Jonkman MF.

J Am Acad Dermatol. 2002 Dec;47(6):919-25. Review.

PMID:
12451379
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk